FLNC Gene Splice Mutations Cause Dilated Cardiomyopathy

JACC: Basic to Translational Science

Volumn 1, Issue 5, 2016, Pages 344-359

  Begay, Rene L ^a   Tharp, Charles A ^a   Martin, August ^b   Graw, Sharon L ^a   Sinagra, Gianfranco ^c   Miani, Daniela ^d   Sweet, Mary E ^a   Slavov, Dobromir B ^a   Stafford, Neil ^b   Zeller, Molly J ^b   Alnefaie, Rasha ^b   Rowland, Teisha J ^a   Brun, Francesca ^c   Jones, Kenneth L ^e   Gowan, Katherine ^e   Mestroni, Luisa ^a   Garrity, Deborah M ^b   Taylor, Matthew R G ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b Department of Ecosystem Science and Sustainability   (United States)

^c UNIVERSITY OF TRIESTE   (Italy)

^d SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^e UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

cardiovascular genetics; dilated cardiomyopathy; filamin C; heart failure; zebrafish

Indexed keywords

EID: 85002603996     PISSN: 2452302X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacbts.2016.05.004     Document Type: Review

References (55)

1. 1 Jefferies, J.L., Towbin, J.A., Dilated cardiomyopathy. Lancet 375 (2010), 752–762.
2. 2 Maron, M.S., Olivotto, I., Zenovich, A.G., et al. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation 114 (2006), 2232–2239.
3. 3 Hershberger, R.E., Cowan, J., Morales, A., Siegfried, J.D., Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Heart Fail 2 (2009), 253–261.
4. 4 Hershberger, R.E., Hedges, D.J., Morales, A., Dilated cardiomyopathy: the complexity of a diverse genetic architecture. Nat Rev Cardiol 10 (2013), 531–547.
5. 5 Parks, S.B., Kushner, J.D., Nauman, D., et al. Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy. Am Heart J 156 (2008), 161–169.
6. 6 Roncarati, R., Viviani Anselmi, C., Krawitz, P., et al. Doubly heterozygous LMNA and TTN mutations revealed by exome sequencing in a severe form of dilated cardiomyopathy. Eur J Hum Genet 21 (2013), 1105–1111.
7. 7 Kley, R.A., Serdaroglu-Oflazer, P., Leber, Y., et al. Pathophysiology of protein aggregation and extended phenotyping in filaminopathy. Brain 135 (2012), 2642–2660.
8. 8 Duff, R.M., Tay, V., Hackman, P., et al. Mutations in the N-terminal actin-binding domain of filamin C cause a distal myopathy. Am J Hum Genet 88 (2011), 729–740.
9. 9 Guergueltcheva, V., Peeters, K., Baets, J., et al. Distal myopathy with upper limb predominance caused by filamin C haploinsufficiency. Neurology 77 (2011), 2105–2114.
10. 10 Luan, X., Hong, D., Zhang, W., Wang, Z., Yuan, Y., A novel heterozygous deletion-insertion mutation (2695-2712 del/GTTTGT ins) in exon 18 of the filamin C gene causes filaminopathy in a large Chinese family. Neuromuscul Disord 20 (2010), 390–396.
11. 11 Tasca, G., Odgerel, Z., Monforte, M., et al. Novel FLNC mutation in a patient with myofibrillar myopathy in combination with late-onset cerebellar ataxia. Muscle Nerve 46 (2012), 275–282.
12. 12 Vorgerd, M., van der Ven, P.F., Bruchertseifer, V., et al. A mutation in the dimerization domain of filamin c causes a novel type of autosomal dominant myofibrillar myopathy. Am J Hum Genet 77 (2005), 297–304.
13. 13 Brodehl, A., Ferrier, R.A., Hamilton, S.J., et al. Mutations in FLNC are associated with familial restrictive cardiomyopathy. Hum Mutat 37 (2016), 269–279.
14. 14 Valdes-Mas, R., Gutierrez-Fernandez, A., Gomez, J., et al. Mutations in filamin C cause a new form of familial hypertrophic cardiomyopathy. Nat Commun, 5, 2014, 5326.
15. 15 Mestroni, L., Maisch, B., McKenna, W.J., et al., for the Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy. Guidelines for the study of familial dilated cardiomyopathies. Eur Heart J 20 (1999), 93–102.
16. 16 Henry, W.L., Gardin, J.M., Ware, J.H., Echocardiographic measurements in normal subjects from infancy to old age. Circulation 62 (1980), 1054–1061.
17. 17 Campbell, N., Sinagra, G., Jones, K.L., et al. Whole exome sequencing identifies a troponin T mutation hot spot in familial dilated cardiomyopathy. PLoS One, 8, 2013, e78104.
18. 18 Wu, T.D., Nacu, S., Fast and SNP-tolerant detection of complex variants and splicing in short reads. Bioinformatics 26 (2010), 873–881.
19. 19 Abecasis, G.R., Auton, A., Brooks, L.D., et al., for the 1,000 Genomes Project Consortium. An integrated map of genetic variation from 1,092 human genomes. Nature 491 (2012), 56–65.
20. 20 Exome Variant Server, NHLBI GO Exome Sequencing Project (ESP), Seattle, WA. Available at: http://evs.gs.washington.edu/EVS/. Accessed November 2014.
21. 21 Endeavor. Endeavour: A Web Resource for Gen Prioritization in Multiple Species. Available at: http://homes.esat.kuleuven.be/∼bioiuser/endeavour/tool/endeavourweb.php. Accessed June 2014.
22. 22 Aerts, S., Lambrechts, D., Maity, S., et al. Gene prioritization through genomic data fusion. Nat Biotechnol 24 (2006), 537–544.
23. 23 Westerfield, M., The Zebrafish Book: A Guide for Laboratory Use of Zebrafish (Brachydanio rerio). 2nd edition, 1993, University of Oregon Press, Eugene, OR.
24. 24 Kimmel, C.B., Ballard, W.W., Kimmel, S.R., Ullmann, B., Schilling, T.F., Stages of embryonic development of the zebrafish. Dev Dyn 203 (1995), 253–310.
25. 25 Ruparelia, A.A., Zhao, M., Currie, P.D., Bryson-Richardson, R.J., Characterization and investigation of zebrafish models of filamin-related myofibrillar myopathy. Hum Mol Genet 21 (2012), 4073–4083.
26. 26 Robu, M.E., Larson, J.D., Nasevicius, A., et al. p53 activation by knockdown technologies. PLoS Genet, 3, 2007, e78.
27. 27 Gene Tools. Available at: www.gene-tools.com. Accessed February 2014.
28. 28 Karlsson, J., von Hofsten, J., Olsson, P.E., Generating transparent zebrafish: a refined method to improve detection of gene expression during embryonic development. Mar Biotechnol (NY) 3 (2001), 522–527.
29. 29 Rowland, T.J., Miller, L.M., Blaschke, A.J., et al. Roes of integrins in human induced pluripotent stem cell growth on Matrigel and vitronectin. Stem Cells Dev 19 (2010), 1231–1240.
30. 30 Burns, C.G., Milan, D.J., Grande, E.J., Rottbauer, W., MacRae, C.A., Fishman, M.C., High-throughput assay for small molecules that modulate zebrafish embryonic heart rate. Nat Chem Biol 1 (2005), 263–264.
31. 31 Johnson, B.M., Garrity, D.M., Dasi, L.P., Quantifying function in the early embryonic heart. J Biomech Eng, 135, 2013, 041006.
32. 32 Johnson, B., Garrity, D., Dasi, L., The transitional cardiac pumping mechanics in the embryonic heart. Cardiovasc Eng Tech 4 (2013), 246–255.
33. 33 Ebert, A.M., Hume, G.L., Warren, K.S., et al. Calcium extrusion is critical for cardiac morphogenesis and rhythm in embryonic zebrafish hearts. Proc Natl Acad Sci U S A 102 (2005), 17705–17710.
34. 34 Exome Aggregation Consortium. ExAC Browser. Available at: http://exac.broadinstitute.org. Accessed February 2016.
35. 35 Bill, B.R., Petzold, A.M., Clark, K.J., Schimmenti, L.A., Ekker, S.C., A primer for morpholino use in zebrafish. Zebrafish 6 (2009), 69–77.
36. 36 Kley, R.A., Hellenbroich, Y., van der Ven, P.F., et al. Clinical and morphological phenotype of the filamin myopathy: a study of 31 German patients. Brain 130 (2007), 3250–3264.
37. 37 Furst, D.O., Goldfarb, L.G., Kley, R.A., et al. Filamin C-related myopathies: pathology and mechanisms. Acta Neuropathol 125 (2013), 33–46.
38. 38 Thompson, T.G., Chan, Y.M., Hack, A.A., et al. Filamin 2 (FLN2): a muscle-specific sarcoglycan interacting protein. J Cell Biol 148 (2000), 115–126.
39. 39 Shatunov, A., Olive, M., Odgerel, Z., et al. In-frame deletion in the seventh immunoglobulin-like repeat of filamin C in a family with myofibrillar myopathy. Eur J Hum Genet 17 (2009), 656–663.
40. 40 Exome Aggregation Consortium, Lek M, Karczewski KJ, et al. Analysis of Protein-Coding Genetic Variation in 60,706 humans. BioRxiv. Available at: http://www.biorxiv.org/content/early/2015/10/30/030338. Accessed March 2016.
41. 41 Pelster, B., Burggren, W.W., Disruption of hemoglobin oxygen transport does not impact oxygen-dependent physiological processes in developing embryos of zebra fish (Danio rerio). Circ Res 79 (1996), 358–362.
42. 42 Schwerte, T., Cardio-respiratory control during early development in the model animal zebrafish. Acta Histochem 111 (2009), 230–243.
43. 43 Hassel, D., Dahme, T., Erdmann, J., et al. Nexilin mutations destabilize cardiac Z-disks and lead to dilated cardiomyopathy. Nat Med 15 (2009), 1281–1288.
44. 44 Hoshijima, M., Mechanical stress-strain sensors embedded in cardiac cytoskeleton: Z disk, titin, and associated structures. Am J Physiol Heart Circ Physiol 290 (2006), H1313–H1325.
45. 45 Pyle, W.G., Solaro, R.J., At the crossroads of myocardial signaling: the role of Z-discs in intracellular signaling and cardiac function. Circ Res 94 (2004), 296–305.
46. 46 Volkers, M., Dolarabadi, N., Gude, N., Most, P., Sussman, M.A., Hassel, D., Orai1 deficiency leads to heart failure and skeletal myopathy in zebrafish. J Cell Sci 125 (2012), 287–294.
47. 47 Knoll, R., Buyandelger, B., Lab, M., The sarcomeric Z-disc and Z-discopathies. J Biomed Biotechnol, 2011, 2011, 569628.
48. 48 Morita, H., Seidman, J., Seidman, C.E., Genetic causes of human heart failure. J Clin Invest 115 (2005), 518–526.
49. 49 Morita, H., Nagai, R., Seidman, J.G., Seidman, C.E., Sarcomere gene mutations in hypertrophy and heart failure. J Cardiovasc Transl Res 3 (2010), 297–303.
50. 50 Grunig, E., Tasman, J.A., Kucherer, H., Franz, W., Kubler, W., Katus, H.A., Frequency and phenotypes of familial dilated cardiomyopathy. J Am Coll Cardiol 31 (1998), 186–194.
51. 51 Chevessier, F., Schuld, J., Orfanos, Z., et al. Myofibrillar instability exacerbated by acute exercise in filaminopathy. Hum Mol Genet 24 (2015), 7207–7220.
52. 52 van der Flier, A., Sonnenberg, A., Structural and functional aspects of filamins. Biochimica Biophys Acta 1538 (2001), 99–117.
53. 53 Golbus, J.R., Puckelwartz, M.J., Dellefave-Castillo, L., et al. Targeted analysis of whole genome sequence data to diagnose genetic cardiomyopathy. Circ Cardiovasc Genet 7 (2014), 751–759.
54. 54 Deo, R.C., Musso, G., Tasan, M., et al. Prioritizing causal disease genes using unbiased genomic features. Genome Biol, 15, 2014, 534.
55. 55 Fujita, M., Mitsuhashi, H., Isogai, S., et al. Filamin C plays an essential role in the maintenance of the structural integrity of cardiac and skeletal muscles, revealed by the medaka mutant zacro. Dev Biol 361 (2012), 79–89.